InvestorsHub Logo
Followers 0
Posts 52
Boards Moderated 0
Alias Born 03/23/2016

Re: None

Wednesday, 03/29/2017 9:09:28 PM

Wednesday, March 29, 2017 9:09:28 PM

Post# of 3545
For newer folks (like myself), I found an article from 2012 which addressed iSperse vs other inhalers such as GSK's Advair (which recently exhaled a sigh of relief when Mylan's generic drug got a CRL). Reading this gave me greater confidence in the company and I can see why Mylan would rather BO Pulmatrix than redo their generic drug again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PULM News